新华制药(000756) - 2018 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2018 was ¥1,417,348,459.35, representing a 9.42% increase compared to ¥1,295,383,415.66 in the same period last year[8] - Net profit attributable to shareholders was ¥67,593,570.18, a 31.12% increase from ¥51,550,425.89 year-on-year[8] - The net profit after deducting non-recurring gains and losses was ¥65,231,667.77, up 52.87% from ¥42,672,569.90 in the previous year[8] - The basic earnings per share increased to ¥0.14, reflecting a growth of 27.27% compared to ¥0.11 in the same period last year[8] - The net profit attributable to shareholders of the listed company for the first quarter of 2018 was RMB 67,593,570.18, an increase of 31.31% year-on-year, driven by strategic product adjustments and increased sales of key products[18] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,422,254,249.93, a 2.82% increase from ¥5,273,647,124.63 at the end of the previous year[8] - The net assets attributable to shareholders were ¥2,514,624,527.68, which is a 1.40% increase from ¥2,480,023,776.59 at the end of the previous year[8] - As of March 31, 2018, the group's accounts receivable amounted to RMB 600,307,857.55, an increase of 92.03% compared to the beginning of the year, primarily due to expanded sales scale and payment terms not yet reached for some sales[17] - As of March 31, 2018, the group's short-term borrowings were RMB 236,336,368.81, up 55.65% from the beginning of the year, mainly to ensure normal production operations[17] - The group's accounts payable increased by 42.45% to RMB 296,627,775.05 as of March 31, 2018, due to an increase in newly opened bank acceptance bills[17] Cash Flow - The net cash flow from operating activities was negative at -¥4,063,722.33, a decline of 107.48% compared to ¥54,305,762.76 in the same period last year[8] - The net cash flow from operating activities for the first quarter of 2018 was RMB -4,063,722.33, a decrease of RMB 58,369,485.09 compared to the same period last year, mainly due to increased accounts receivable[18] - The net cash flow from investing activities for the first quarter of 2018 was RMB -55,630,239.47, an increase of RMB 45,186,570.90 year-on-year, mainly due to reduced cash payments for fixed asset purchases[18] Financial Ratios and Returns - The weighted average return on equity was 2.71%, slightly up from 2.56% in the previous year[8] Government Support and Shareholder Information - The company received government subsidies amounting to ¥2,553,700.01 during the reporting period[9] - The total number of shareholders at the end of the reporting period was 29,832[12] Other Financial Metrics - The financial expenses for the first quarter of 2018 were RMB 21,943,379.69, an increase of 38.19% year-on-year, primarily due to increased exchange losses[17] - The group's prepayments as of March 31, 2018, were RMB 37,163,071.80, up 62.95% from the beginning of the year, due to increased procurement payments to ensure normal operations[17] - The group's other current assets decreased by 82.95% to RMB 10,562,229.56 as of March 31, 2018, mainly due to a reduction in VAT credits[17] - The group's deferred income tax liabilities decreased by 32.10% to RMB 11,604,407.89 as of March 31, 2018, influenced by changes in the fair value of available-for-sale financial assets[17]